The FDA is seeking a cap on nicotine levels in cigarettes and certain tobacco products at minimally or nonaddictive levels. This initiative, if finalized, would be what the FDA calls a “significant step”...
A ceramide and niacinamide-containing moisturizer (CCM) significantly enhances acne treatment outcomes by reducing lesions and improving skin barrier function when used alongside standard anti-acne...
Researchers recently published a survey that aimed at evaluating public awareness of postmenopausal bleeding as a symptom of endometrial cancer. Do you know the survey findings? Test your knowledge with...
Researchers developed a cross-sectional survey to understand the public and provider awareness of postmenopausal bleeding as a symptom of endometrial cancer.
In July 2024, WHO updated its guidelines with new recommendations to improve access to HIV post-exposure prophylaxis (PEP), which involves the administration of antiretroviral medications to individuals at...
The FDA has approved concizumab-mtci, a daily subcutaneous treatment to reduce bleeding for patients with hemophilia who have clotting factor inhibitors.
Crinecerfont, a first-in-class therapy, improved androgen control and reduced reliance on high-dose glucocorticoids for patients with congenital adrenal hyperplasia.
The efficacy and safety of several medications have been examined for treating COVID-19 infections of varying severity. Do you know which medication therapies are currently recommended for use in...
